Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
FDA Warning Letter Blasts Mylan’s Continued Lax Impurity Controls for APIs
Company Needs To Beef Up Equipment Cleaning And Monitoring Of Recovered Solvents For Impurities
Sep 01 2020
•
By
Joanne S. Eglovitch
FDA Tells Mylan To Learn From Earlier Mistakes • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Manufacturing
More from Compliance